Trading Report: Today, Israel Chemicals Ltd. (ICL) Announces Earnings Results, Hits Estimates

Today, Israel Chemicals Ltd. (ICL) Announces  Earnings Results, Hits Estimates

Israel Chemicals Ltd. (NYSE:ICL) posted its quarterly earnings results on Wednesday. The company reported $0.09 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.09. The business earned $1.38 billion during the quarter. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The firm’s revenue for the quarter was up .3% on a year-over-year basis. During the same quarter last year, the business posted $0.12 earnings per share.

Israel Chemicals (NYSE:ICL) traded down 2.63% during trading on Friday, reaching $3.70. The company had a trading volume of 38,070 shares. The stock has a market cap of $4.71 billion, a P/E ratio of 11.67 and a beta of 1.14. Israel Chemicals has a 12-month low of $3.52 and a 12-month high of $5.23. The firm has a 50-day moving average price of $3.74 and a 200 day moving average price of $3.99.

Separately, Zacks Investment Research upgraded Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Thursday, August 11th.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ICL. First Eagle Investment Management LLC increased its position in Israel Chemicals by 0.3% in the second quarter. First Eagle Investment Management LLC now owns 29,583,977 shares of the company’s stock worth $114,362,000 after buying an additional 97,067 shares during the period. Vanguard Group Inc. increased its position in shares of Israel Chemicals by 1.5% in the second quarter. Vanguard Group Inc. now owns 8,841,883 shares of the company’s stock worth $34,484,000 after buying an additional 131,595 shares during the period. Migdal Insurance & Financial Holdings Ltd. purchased a new position in shares of Israel Chemicals during the second quarter worth approximately $11,135,000. Allianz Asset Management AG increased its position in shares of Israel Chemicals by 67.0% in the second quarter. Allianz Asset Management AG now owns 2,020,656 shares of the company’s stock worth $7,829,000 after buying an additional 810,656 shares during the period. Finally, Foyston Gordon & Payne Inc increased its position in shares of Israel Chemicals by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock worth $7,834,000 after buying an additional 16,631 shares during the period. 6.51% of the stock is owned by institutional investors and hedge funds.

Related posts

Leave a Comment